Key result
Rigorous cardiac evaluation is essential in immune-mediated thrombotic thrombocytopenic purpura to distinguish fulminant myocarditis from microvascular ischemia for appropriate treatment.
Highlights the importance of distinguishing between myocarditis and microvascular ischemia in iTTP patients with cardiac dysfunction to guide appropriate management.
We commented on a recent case report of fulminant myocarditis in immune‐mediated thrombotic thrombocytopenic purpura (iTTP). While the authors attributed cardiac dysfunction to myocarditis, we caution that microvascular ischemia remains a plausible mechanism, given the clinical context and nonspecific imaging. Diagnostic clarity is essential because therapeutic strategies may differ from one another. We advocated for a rigorous cardiac evaluation in patients with iTTP to inform appropriate management.
No takes yet. Share an insight, caveat, or question.
Satapathy et al. (2026) studied this question. Rigorous cardiac evaluation is essential in immune-mediated thrombotic thrombocytopenic purpura to distinguish fulminant myocarditis from microvascular ischemia for appropriate treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: